Diagnostik der pulmonalen Hypertonie[¹]

Literatur

• 1 Agusti A NG, Rodriguez-Roisin R. Effect of pulmonary hypertension on the gas exchange.  Eur Respir J. 1993;  6 1371-1377
• 2 Asherson R A, Cervera R. Review: Antiphospholipid antibodies and the lung.  J Rheumatol. 1995;  22 62-66
• 3 Bankier A A. New techniques in the imaging of pulmonary embolism: why and how spiral computed tomography will alter the diagnostic algorithms.  Eur Respir Top. 1998;  4 1-5
• 4 Bittner R C, Felix R. Magnetic resonance (MR) imaging of the chest: state-of-the-art.  Eur Respir J. 1998;  11 1392-1404
• 5 Burke C, Glanville A R, Morris A JR. et al . Pulmonary function in advanced pulmonary hypertension.  Thorax. 1987;  42 131-135
• 6 Dickinson C J. The aetiology of clubbing and hypertrophic osteoartropathy.  Eur J Clin Invest. 1993;  23 330-338
• 7 Erbel R, Drozdz J, Ge J. et al . Bildgebende Verfahren in der Kardiologie.  Internist. 1994;  35 1039-1055
• 8 Ewert R, Modersohn D, Meyer R, Gellert K, Kleber F X. Histologische Materialgewinnung bei pulmonaler Hypertonie mittels perkutaner, transvasaler Biopsie (PTB)- tierexperimentelle und erste klinische Daten.  Z Kardiol. 1997;  86 622-629
• 9 Garofano R P, Barst R J. Exercise testing in children with primary pulmonary hypertension.  Pediatr Cardiol. 1999;  20 61-64
• 10 Henk C B, Gabriel H, Fleischmann D, Schoder M, Mostbeck G H. Pulmonale Hypertension und Cor pulmonale.  Radiologe. 1997;  37 388-401
• 11 Hoeper M M, Maier R, Tongers J, Niedermeyer J. et al . Determination of cardiac output by the Fick method, thermodilution, and actethylene rebreathing in pulmonary hypertension.  Am J Respir Crit Care Med. 1999;  160 535-541
• 12 Hoeper M M, Hohlfeld J M, Fabel H. Hyperuricaemia in patients with right or left heart failure.  Eur Respir J. 1999;  13 682-685
• 13 Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation.  J Heart Lung Transplant. 1997;  16 313-319
• 14 Naum C C, Sciurba F C, Rogers R M. Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation.  Am Rev Respir Dis. 1992;  145 1334-1338
• 15 Nootens M, Wolfkiel C J, Chomka E V, Rich S. Understanding right and left ventricular function and interactions at rest and with exercise in primary pulmonary hypertension.  Am J Cardiol. 1995;  75 374-377
• 16 Olschewski H, Ghofrani H A, Walmrath D. et al . Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.  Am J Crit Care Med. 1999;  160 600-607
• 17 Palevsky H I, Long W, Crow J, Fishman A P. Prostacyclin and acethylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension.  Circulation. 1990;  82 2018-2026
• 18 Rademaker J, Galanski M. Wert der Spiral-Computertomographie in der Diagnostik der akuten Lungenembolie.  Dtsch Med Wochenschr. 1999;  124 153-157
• 19 Ricciardi M J, Knight B P, Martinez F J, Rubenfire M. Inhaled nitric oxide in primary pulmonary hypertension. A safe and effective agent for predicting response to nifedipine.  J Am Coll Cardiol. 1998;  32 1068-1073
• 20 Rich S, Chomka E, Hasara L. et al . The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II survey.  Chest. 1989;  96 236-241
• 21 Rich S. World Symposium on Primary Pulmonary Hypertension 1998: Executive Summary. http://www.who.int/ncd/cvd/pph.html
• 22 Rich S, Dantzker D R, Ayres S M. et al . Primary pulmonary hypertension- a national prospective study.  Ann Intern Med. 1987;  107 216-223
• 23 Rubin L J. Primary pulmonary hypertension.  N Engl J Med. 1997;  336 111-117
• 24 Rubin L J. ACCP consensus statement: Primary pulmonary hypertension.  Chest. 1993;  104 236-250
• 25 Rubin L J. Brenot Memorial Symposium on the Pathogenesis of Primary Pulmonary Hypertension.  Chest. 1998;  114 183S-247S
• 26 Sitbon O, Humbert M, Jagot J L. et al . Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.  Eur Respir J. 1998;  12 265-270
• 27 Steiniger L. Aktuelle Aspekte der Diagnostik des chronischen Cor pulmonale.  Innere Medizin. 1993;  48 532-537
• 28 Vignon P, Weinert L, Mor-Avi V, Spencer K T, Bednarz J, Lang R M. Quantitative assessment of regional right ventricular function with color kinesis.  Am Respir Crit Care Med. 1999;  159 1949-1959
• 29 Wensel R, Opitz C F, Ewert R, Bruch L, Kleber F X. Effects of iloprost inhalation on exercise capacity and ventilatory effiency in patients with primary pulmonary hypertension.  Circulation. 2000;  101 2388-2392

551 Der Beitrag »Medikamentöse Langzeitbehandlung der pulmonalen Hypertonie« erscheint im nächsten Heft (Nr. 12)

Korrespondenz